Triple Ring Technologies is proud to sponsor the
Life Science Angels.
Life Science Angels, Inc. was founded in 2004 by
senior life science executives and experienced angel investors as a vehicle to bring angel capital to worthy early-stage
biotech and medical device companies. Formally launched in January 2005 with backing of 15 industry sponsors, LSA follows a
rigorous due diligence process before presenting investment opportunites to its membership. LSA also works with select angel
groups, venture capitalists, and outside investors to syndicate opportunities requiring larger investments.
Life Science Angels (LSA) portfolio companies are improving the standard of care across a broad spectrum of therapeutic and diagnostic areas. Since 2005, LSA has invested approximately $32M in 35 companies, which have received an additional $600+million in follow-on funding from venture capital firms. Three LSA portfolio companies have been acquired and one has completed its initial public offering: NSpine (acquired by Synthes), Textronics (acquired by Adidas International), Vasonova (acquired by Telemedix), and Zogenix (NASDAQ: ZGNX). Additionally, Nanostim has announced a investment agreement with St. Jude Medical, which includes the option to purchase the company for a specified sum.
Our monthly MedTech Frontiers gathering features a prominent thought-leader. Please join us. Click here for more information.
Triple Ring Technologies is currently looking for a few exceptionally talented individuals. For more information, click here.
